Your browser doesn't support javascript.
loading
Mechanistic Middle-Out Physiologically Based Toxicokinetic Modeling of Transporter-Dependent Disposition of Perfluorooctanoic Acid in Humans.
Lin, Jieying; Chin, Sheng Yuan; Tan, Shawn Pei Feng; Koh, Hor Cheng; Cheong, Eleanor Jing Yi; Chan, Eric Chun Yong; Chan, James Chun Yip.
Afiliación
  • Lin J; Innovations in Food and Chemical Safety (IFCS) Programme, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Matrix #07-01, Singapore 138671, Republic of Singapore.
  • Chin SY; A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #06-06, Singapore 138648 , Republic of Singapore.
  • Tan SPF; Innovations in Food and Chemical Safety (IFCS) Programme, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Matrix #07-01, Singapore 138671, Republic of Singapore.
  • Koh HC; Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos #01-02, Singapore 138669, Republic of Singapore.
  • Cheong EJY; Innovations in Food and Chemical Safety (IFCS) Programme, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Matrix #07-01, Singapore 138671, Republic of Singapore.
  • Chan ECY; A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #06-06, Singapore 138648 , Republic of Singapore.
  • Chan JCY; Innovations in Food and Chemical Safety (IFCS) Programme, Agency for Science, Technology and Research (A*STAR), 30 Biopolis Street, Matrix #07-01, Singapore 138671, Republic of Singapore.
Environ Sci Technol ; 57(17): 6825-6834, 2023 05 02.
Article en En | MEDLINE | ID: mdl-37072124
Perfluorooctanoic acid (PFOA) is an environmental toxicant exhibiting a years-long biological half-life (t1/2) in humans and is linked with adverse health effects. However, limited understanding of its toxicokinetics (TK) has obstructed the necessary risk assessment. Here, we constructed the first middle-out physiologically based toxicokinetic (PBTK) model to mechanistically explain the persistence of PFOA in humans. In vitro transporter kinetics were thoroughly characterized and scaled up to in vivo clearances using quantitative proteomics-based in vitro-to-in vivo extrapolation. These data and physicochemical parameters of PFOA were used to parameterize our model. We uncovered a novel uptake transporter for PFOA, highly likely to be monocarboxylate transporter 1 which is ubiquitously expressed in body tissues and may mediate broad tissue penetration. Our model was able to recapitulate clinical data from a phase I dose-escalation trial and divergent half-lives from clinical trial and biomonitoring studies. Simulations and sensitivity analyses confirmed the importance of renal transporters in driving extensive PFOA reabsorption, reducing its clearance and augmenting its t1/2. Crucially, the inclusion of a hypothetical, saturable renal basolateral efflux transporter provided the first unified explanation for the divergent t1/2 of PFOA reported in clinical (116 days) versus biomonitoring studies (1.3-3.9 years). Efforts are underway to build PBTK models for other perfluoroalkyl substances using similar workflows to assess their TK profiles and facilitate risk assessments.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Caprilatos / Fluorocarburos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Environ Sci Technol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Caprilatos / Fluorocarburos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Environ Sci Technol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos